Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter August 24, 2013

Still more discussion on the journal impact factor

  • Emmanuel J. Favaloro EMAIL logo

Corresponding author: Emmanuel J. Favaloro, PhD FFSc (RCPA), Institute of Clinical Pathology and Medical Research (ICPMR), Department of Haematology, Pathology West, Westmead Hospital, Westmead, NSW, Australia, Phone: +612 98456618, Fax: +612 6892331, E-mail:

References

1. Diamandis EP. More discussion on journal impact factor. Clin Chem Lab Med 2013;51:2271.10.1515/cclm-2013-0515Search in Google Scholar PubMed

2. Diamandis EP. Journal impact factor: it will go away soon. Clin Chem Lab Med 2009;47:1317–8.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000272257700017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

3. Favaloro EJ. The journal impact factor: don’t expect its immediate demise any time soon. Clin Chem Lab Med 2009;47:1319–24.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000272257700018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar

4. Plebani M. The journal impact factor: navigating between Scylla and Charybdis. Clin Chem Lab Med 2009;47:1315–6.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000272257700016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

5. Lippi G, Mattiuzzi C. The challenges of evaluating scientists by H-index and citations in different biomedical research platforms. Clin Chim Acta 2013;421:57–8.10.1016/j.cca.2013.02.024http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000320220900010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

6. Favaloro EJ. Measuring the quality of journals and journal articles: the impact factor tells but a portion of the story. Semin Thromb Hemost 2008;34:7–25.10.1055/s-2008-1066030http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000255122700002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

7. Favaloro EJ. More on the impact factor and thrombosis and haemostasis journals: benefits and limitations. Thromb Haemost 2007;98:475–6.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000248807800033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

8. Lippi G. The impact factor for evaluating scientists: the good, the bad and the ugly. Clin Chem Lab Med 2009;47:1585–6.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000272257900024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

Received: 2013-08-07
Accepted: 2013-08-07
Published Online: 2013-08-24
Published in Print: 2013-12-01

©2013 by Walter de Gruyter Berlin Boston

Downloaded on 7.5.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2013-0628/html
Scroll to top button